Back
Also listed as
EVOTF
OTC
Day Range
$2.34
$2.42
52-Week Range
$2.31
$4.80
Volume
79,013
50D / 200D Avg
$3.33
/
$3.58
Prev Close
$2.38
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -4.2 | 0.3 |
| P/B | 0.9 | 2.9 |
| ROE % | -18.9 | 3.7 |
| Net Margin % | -24.6 | 3.8 |
| Rev Growth 5Y % | 12.3 | 10.0 |
| D/E | 0.5 | 0.2 |
Analyst Price Target
Hold
$7.00
+199.1%
Forward EPS
-$0.16
Est. Revenue
790 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2029 |
$0.23
$0.22 – $0.26
|
960 M | 1 |
| FY2028 |
$0.14
$0.13 – $0.16
|
900 M | 1 |
| FY2027 |
$0.02
$0.02 – $0.02
|
860 M | 1 |
Key Takeaways
Revenue grew 12.31% annually over 5 years — strong growth
Debt/Equity of 0.47 — conservative balance sheet
Negative free cash flow of -114.02M
Revenue growth is decelerating — 1Y growth trails 5Y average by 10.32%
Growth
Revenue Growth (5Y)
12.31%
Revenue (1Y)1.99%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-18.92%
ROIC-7.66%
Net Margin-24.60%
Op. Margin-17.88%
Safety
Debt / Equity
0.47
Current Ratio1.98
Interest Coverage-12.18
Valuation
P/E Ratio
-4.24
P/B Ratio0.87
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 1.99% | Revenue Growth (3Y) | 2.98% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 12.31% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 796.97M | Net Income (TTM) | -196.08M |
| ROE | -18.92% | ROA | -10.25% |
| Gross Margin | 14.41% | Operating Margin | -17.88% |
| Net Margin | -24.60% | Free Cash Flow (TTM) | -114.02M |
| ROIC | -7.66% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.47 | Current Ratio | 1.98 |
| Interest Coverage | -12.18 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -4.24 | P/B Ratio | 0.87 |
| P/S Ratio | 1.04 | PEG Ratio | -0.05 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 831.69M | Enterprise Value | 968.84M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 796.97M | 781.43M | 751.45M | 618.03M | 500.92M |
| Net Income | -196.08M | -83.91M | -175.66M | 215.51M | 6.28M |
| EPS (Diluted) | -0.56 | -0.23 | -0.49 | 0.65 | 0.02 |
| Gross Profit | 114.88M | 175.05M | 174.07M | 151.54M | 125.74M |
| Operating Income | -142.52M | -47.51M | 20.85M | 41.00M | 48.56M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 1.91B | 2.25B | 2.26B | 2.24B | 1.84B |
| Total Liabilities | 959.98M | 1.13B | 1.07B | 857.48M | 951.26M |
| Shareholders' Equity | 952.53M | 1.12B | 1.19B | 1.38B | 886.41M |
| Total Debt | 443.54M | 815.35M | 506.67M | 512.92M | 601.94M |
| Cash & Equivalents | 306.39M | 510.91M | 400.70M | 699.33M | 517.05M |
| Current Assets | 681.96M | 903.16M | 1.07B | 1.10B | 806.13M |
| Current Liabilities | 344.59M | 464.57M | 337.71M | 324.52M | 255.06M |